Logo image of QNTM

QUANTUM BIOPHARMA LTD (QNTM) Stock Price, Quote, News and Overview

NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD

6.71  +3.53 (+111.01%)

After market: 6.38 -0.33 (-4.92%)

QNTM Quote, Performance and Key Statistics

QUANTUM BIOPHARMA LTD

NASDAQ:QNTM (2/4/2025, 5:33:59 PM)

After market: 6.38 -0.33 (-4.92%)

6.71

+3.53 (+111.01%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap12.88M
Shares1.92M
Float1.66M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO05-29 2018-05-29


QNTM short term performance overview.The bars show the price performance of QNTM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

QNTM long term performance overview.The bars show the price performance of QNTM in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of QNTM is 6.71 USD. In the past month the price increased by 67.33%.

QUANTUM BIOPHARMA LTD / QNTM Daily stock chart

QNTM Latest News, Press Releases and Analysis

News Image
3 hours ago - Chartmill

Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

News Image
5 hours ago - Chartmill

Tuesday's session: top gainers and losers

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

News Image
7 hours ago - Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session.

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

News Image
9 hours ago - Chartmill

Discover the top movers in Tuesday's pre-market session.

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
3 hours ago - Benzinga

Quantum BioPharma Shares Are Up Today: What's Going On?

Shares of Quantum BioPharma Ltd. (NASDAQ: QNTM) are soaring more than 70% on Tuesday after the company announced positive clinical trial results for its dietary supplement, unbuzzd, which accelerates the reduction of blood alcohol concentration.

QNTM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 81.23 784.20B
JNJ JOHNSON & JOHNSON 15.36 369.55B
NVO NOVO-NORDISK A/S-SPONS ADR 28.2 366.85B
MRK MERCK & CO. INC. 15.25 229.54B
AZN ASTRAZENECA PLC-SPONS ADR 18.1 213.85B
NVS NOVARTIS AG-SPONSORED ADR 13.32 210.86B
PFE PFIZER INC 10.03 146.61B
SNY SANOFI-ADR 14.82 134.13B
BMY BRISTOL-MYERS SQUIBB CO 50.53 119.91B
ZTS ZOETIS INC 29.9 77.71B
GSK GSK PLC-SPON ADR 8.46 71.08B
TAK TAKEDA PHARMACEUTIC-SP ADR 22.2 42.23B

About QNTM

Company Profile

QNTM logo image Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Company Info

QUANTUM BIOPHARMA LTD

First Canadian Place, 100 King Street West, Suite 4000

TORONTO ONTARIO CA

Employees: 10

Company Website: https://www.fsdpharma.com/

Investor Relations: http://www.fsdpharma.com/investors

Phone: 14168548884

QNTM FAQ

What is the stock price of QNTM?

The current stock price of QNTM is 6.71 USD.


What is the symbol for QUANTUM BIOPHARMA LTD stock?

The exchange symbol of QUANTUM BIOPHARMA LTD is QNTM and it is listed on the Nasdaq exchange.


On which exchange is QNTM stock listed?

QNTM stock is listed on the Nasdaq exchange.


Is QNTM a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for QNTM, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of QNTM.


Does QNTM stock pay dividends?

QNTM does not pay a dividend.


What is the Short Interest ratio of QNTM stock?

The outstanding short interest for QNTM is 2.46% of its float.


QNTM Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to QNTM.


Chartmill TA Rating
Chartmill Setup Rating

QNTM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

QNTM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to QNTM. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners1.54%
Ins Owners12.95%
Short Float %2.46%
Short Ratio0.32
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A